File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1034/j.1601-0825.2001.0070103.x
- Scopus: eid_2-s2.0-0035107647
- PMID: 11354914
- WOS: WOS:000167595100003
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Adjunctive use of chlorhexidine in oral candidoses: A review
Title | Adjunctive use of chlorhexidine in oral candidoses: A review |
---|---|
Authors | |
Keywords | Chlorhexidine Oral candidoses |
Issue Date | 2001 |
Publisher | Wiley-Blackwell Publishing, Inc.. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=1354-523X&site=1 |
Citation | Oral Diseases, 2001, v. 7 n. 1, p. 11-17 How to Cite? |
Abstract | Oral candidosis is by far the commonest human fungal infection and manifests in a variety of clinical guises. The main reason for its high incidence appears to be the multiplicity of predisposing factors, which facilitate the conversion of oral commensal Candida to a parasitic existence. Despite the availability of a number of effective antimycotics for the treatment of oral candidoses, failure of therapy is not uncommon owing to the unique environment of the oral cavity where the flushing effect of saliva and the cleansing action of the oral musculature tend to reduce the drug concentration to sub-therapeutic levels. For these and other reasons chlorhexidine is widely prescribed in dentistry both as an antiseptic mouthwash and a denture disinfectant in order to supplement other antifungals. Chlorhexidine has a broad spectrum of antimicrobial activity including Candida albicans and other common non-albicans yeast species. In this review we outline the utility of chlorhexidine as an adjunct to conventional antimycotic therapy in the management of oral Candida infections. |
Persistent Identifier | http://hdl.handle.net/10722/67254 |
ISSN | 2023 Impact Factor: 2.9 2023 SCImago Journal Rankings: 0.895 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ellepola, ANB | en_HK |
dc.contributor.author | Samaranayake, LP | en_HK |
dc.date.accessioned | 2010-09-06T05:53:16Z | - |
dc.date.available | 2010-09-06T05:53:16Z | - |
dc.date.issued | 2001 | en_HK |
dc.identifier.citation | Oral Diseases, 2001, v. 7 n. 1, p. 11-17 | en_HK |
dc.identifier.issn | 1354-523X | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/67254 | - |
dc.description.abstract | Oral candidosis is by far the commonest human fungal infection and manifests in a variety of clinical guises. The main reason for its high incidence appears to be the multiplicity of predisposing factors, which facilitate the conversion of oral commensal Candida to a parasitic existence. Despite the availability of a number of effective antimycotics for the treatment of oral candidoses, failure of therapy is not uncommon owing to the unique environment of the oral cavity where the flushing effect of saliva and the cleansing action of the oral musculature tend to reduce the drug concentration to sub-therapeutic levels. For these and other reasons chlorhexidine is widely prescribed in dentistry both as an antiseptic mouthwash and a denture disinfectant in order to supplement other antifungals. Chlorhexidine has a broad spectrum of antimicrobial activity including Candida albicans and other common non-albicans yeast species. In this review we outline the utility of chlorhexidine as an adjunct to conventional antimycotic therapy in the management of oral Candida infections. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Wiley-Blackwell Publishing, Inc.. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=1354-523X&site=1 | en_HK |
dc.relation.ispartof | Oral Diseases | en_HK |
dc.subject | Chlorhexidine | - |
dc.subject | Oral candidoses | - |
dc.subject.mesh | Anti-Infective Agents, Local - adverse effects - pharmacology - therapeutic use | en_HK |
dc.subject.mesh | Antifungal Agents - therapeutic use | en_HK |
dc.subject.mesh | Bacterial Adhesion - drug effects | en_HK |
dc.subject.mesh | Candida - drug effects | en_HK |
dc.subject.mesh | Candidiasis, Oral - drug therapy | en_HK |
dc.subject.mesh | Chlorhexidine - adverse effects - pharmacology - therapeutic use | en_HK |
dc.subject.mesh | Drug Delivery Systems | en_HK |
dc.subject.mesh | Drug Synergism | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Tooth Discoloration - etiology | en_HK |
dc.title | Adjunctive use of chlorhexidine in oral candidoses: A review | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1354-523X&volume=7&spage=11&epage=17&date=2001&atitle=Adjunctive+use+of+chlorhexidine+in+oral+candidoses:+a+review | en_HK |
dc.identifier.email | Samaranayake, LP:lakshman@hku.hk | en_HK |
dc.identifier.authority | Samaranayake, LP=rp00023 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1034/j.1601-0825.2001.0070103.x | en_HK |
dc.identifier.pmid | 11354914 | - |
dc.identifier.scopus | eid_2-s2.0-0035107647 | en_HK |
dc.identifier.hkuros | 56569 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0035107647&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 7 | en_HK |
dc.identifier.issue | 1 | en_HK |
dc.identifier.spage | 11 | en_HK |
dc.identifier.epage | 17 | en_HK |
dc.identifier.isi | WOS:000167595100003 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Ellepola, ANB=6604060863 | en_HK |
dc.identifier.scopusauthorid | Samaranayake, LP=7102761002 | en_HK |
dc.identifier.issnl | 1354-523X | - |